Tekla Capital Management LLC Molecular Templates, Inc. Transaction History

Tekla Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.78 - $7.86 $1.15 Million - $1.57 Million	-199,420 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.33 - $14.05 $190,350 - $286,648	-20,402 Reduced 9.28%	199,420 $2.52 Million
Q3 2020 Nov 13, 2020	BUY	$9.99 - $14.41 $1.77 Million - $2.56 Million	177,509 Added 419.51%	219,822 $2.4 Million
Q4 2019 Feb 13, 2020	SELL	$6.44 - $14.21 $655,572 - $1.45 Million	-101,797 Reduced 70.64%	42,313 $592,000
Q2 2018 Aug 13, 2018	BUY	$5.19 - $9.71 $473,426 - $885,736	91,219 Added 172.47%	144,110 $754,000
Q1 2018 May 14, 2018	BUY	$8.0 - $12.96 $423,128 - $685,467	52,891 New	52,891 $423,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $19.2M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.